AstraZeneca PLC×PULSE INSIGHTS

The guided experience AstraZeneca asked for — now resolving friction in-session on Imfinzi, Farxiga, and Lokelma.

A live working hub for the AstraZeneca digital and commercial team. Every asset we build lands here — built on the same Pulse tag already on your sites.

Projected savings · AstraZeneca
$1.2M
directional first-year value from a two-brand agent pilot — model every assumption in the ROI calculator
A AstraZeneca rider, in their own words

“We asked for a guided experience. The Tagrisso implementation sat 1,337 days and never shipped; Precision Med's waited 384 days, then the account churned.”

Library

ROI
ROI Calculator
ROI Calculator

AstraZeneca ROI Calculator — your numbers, live

Adjust sessions, friction rate, agent engagement, and value per resolved event. The model returns AZ-specific savings-card recovery and script-lift projections in real time.

Aug 2026Open →
VoC + Agent Strategy
VoC + Agent Strategy

AstraZeneca — Enterprise VoC + Agent Strategy

The four-layer enterprise program: standardized measurement, intervention agents, proof of impact (script lift), and the cross-brand intelligence that compounds with every brand.

Aug 2026Open →
VoC + Agent Strategy
VoC + Agent Strategy

Lokelma — VoC + Agent Strategy

What the survey found on Lokelma, what the agent resolves in-session, the measurement plan, and the pilot scope with a single success metric.

Aug 2026Open →
Custom Demo Agent
Custom Demo Agent

Farxiga Savings Agent — the breakage rescue

A live agent that catches the Medicare-exclusion dead-end on the savings flow and offers an honest off-ramp to AZ&Me before the patient abandons.

Jul 2026Launch →
Custom Demo Agent
Custom Demo Agent

Imfinzi HCP Agent — the digital rep across 8 indications

A live agent that asks which patient the oncologist is treating and routes to the right trial, dosing, and rep — across all eight Imfinzi indications.

Jul 2026Launch →
Custom Demo Agent
Custom Demo Agent

Lokelma HCP Agent — the RAASi-continuation moment

A live agent on a Lokelma HCP surface: it meets the prescriber at the hyperkalemia decision and supports keeping the patient on RAASi. The beachhead.

Jul 2026Launch →
Personalized Landing Page
Personalized Landing Page

AstraZeneca's Live Campaign Hub

This page. Bookmark it — every asset we build for AstraZeneca lands here, accessible to your whole team.

Jun 2026Open →
Friction Analysis
Friction Analysis

AstraZeneca — Where Your Surfaces Lose the Decision (Spring 2026)

A read on where AZ's HCP and DTC surfaces lose the prescriber or patient mid-decision — indication routing, biomarker pathways, the savings-card dead-end — with the agent opportunity mapped to each.

Jun 2026Open →